Spots Global Cancer Trial Database for Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
Official Title: Phase II Clinical Study of Bevacizumab in Combination With Capecitabine as First-line Treatment in Elderly Patients With Metastatic Breast Cancer
Study ID: NCT01195298
Interventions
Study Description
Brief Summary: This is an open-label, single-arm, multicenter study of capecitabine and bevacizumab administered as first-line treatment of previously untreated elderly patients, older than 70 years, with metastatic or locally recurrent breast cancer.
Detailed Description:
Eligibility
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinical Hospital Split, Center of oncology, Split, , Croatia
Contact Details
Name: Eduard Vrdoljak, PhD MD
Affiliation: Clinical Hospital Split, Center of oncology, Croatia
Role: PRINCIPAL_INVESTIGATOR
Name: Damir Vrbanec, PhD MD
Affiliation: Clinical Hospital Zagreb, Croatia
Role: PRINCIPAL_INVESTIGATOR
Name: Katarina Petrakova, MD
Affiliation: Masaryk Memorial Cancer Institue, Brno, Czech Republic
Role: PRINCIPAL_INVESTIGATOR
Name: Gyorgy Bodoky, PhD MD
Affiliation: FOVAROSI SZENT LASZLO KORHAZ-RENDELOINTEZET, ONKOLOGIAI OSZTALY, Budapest, Hungary
Role: PRINCIPAL_INVESTIGATOR
Name: Tamas Pinter, MD
Affiliation: Petz, Aladar Korhaz, Onkoradiologiai Osztaly, Gyor, Hungary
Role: PRINCIPAL_INVESTIGATOR
Name: Vladimir Todorović, MD
Affiliation: Oncology clinic, Clinical Center of Montenegro
Role: PRINCIPAL_INVESTIGATOR
Name: Marek Wojtukiewicz, PhD MD
Affiliation: Department of Oncology Medical University, Bialystok, Poland
Role: PRINCIPAL_INVESTIGATOR
Name: Tadeusz Pienkowski, PhD MD
Affiliation: Cancer Centre and Institute of Oncology Warsaw
Role: PRINCIPAL_INVESTIGATOR
Name: Daniela Grecea, MD
Affiliation: "Prof Dr. I Chiricuta" Cluj Napoca Oncology Institute - Breast Cancer Center, Cluj Napoca, Romania
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
